You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

Article Text

Article menu

See original article:

Download PDFPDF

XML
Erratum
Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1
  1. Marc Uemura1,
  2. Faisal Fa’ak1,
  3. Cara Haymaker1,
  4. Natalie McQuail1,
  5. Elizabeth Sirmans1,
  6. Courtney W. Hudgens2,
  7. Lydia Barbara1,
  8. Chantale Bernatchez1,
  9. Jonathan L. Curry2,
  10. Patrick Hwu1,
  11. Michael T. Tetzlaff2 and
  12. Adi Diab1,l
  1. Aff1 grid.240145.60000000122914776Department of Melanoma Medical OncologyUniversity of Texas-MD Anderson Cancer Center Houston TX USA
  2. Aff2 grid.240145.60000000122914776Department of PathologyUniversity of Texas-MD Anderson Cancer Center Houston TX USA
  1. ↵l adiab{at}mdanderson.org

  • The online version of the original article can be found under doi:10.1186/s40425-016-0157-6.

http://dx.doi.org/10.1186/s40425-017-0208-7

Statistics from Altmetric.com

    Erratum

    Unfortunately, after publication of this article [1], it was noticed that the name of the second author was incorrectly displayed as Faa’k Faisal. The correct name is Faisal Fa’ak and can be seen in the corrected author list above. The original article has also been updated to correct this error.

    Reference

    1. 1.↵
      2. Uemura M ,
      3. Fa’ak F ,
      4. Haymaker C ,
      5. McQuail N ,
      6. Sirmans E ,
      7. Hudgens CW ,
      8. Barbara L ,
      9. Bernatchez C ,
      10. Curry JL ,
      11. Hwu P ,
      12. Tetzlaff MT ,
      13. Diab A
      . A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. J Immunother Cancer.. 2016;4:55 doi:10.1186/s40425-016-0157-6 pmcid:5028978
      OpenUrlAbstract/FREE Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.